The University of Southampton
University of Southampton Institutional Repository

The tumour antigens RAGE-1 and MGEA6 are expressed more frequently in the less lineage restricted subgroups of presentation acute myeloid leukaemia

The tumour antigens RAGE-1 and MGEA6 are expressed more frequently in the less lineage restricted subgroups of presentation acute myeloid leukaemia
The tumour antigens RAGE-1 and MGEA6 are expressed more frequently in the less lineage restricted subgroups of presentation acute myeloid leukaemia
We have analysed the frequency of present calls for RAGE-1 and MGEA6 in patients based on FAB subclass. MGEA6 and RAGE-1 present calls were significantly higher in the M0/M1/M2 versus the M3/M4/M5/M6/M7 groups for both RAGE-1 (p<0.0001) and MGEA6 (p<0.0001). However dividing patients into three WHO subgroups as follows (i) ‘recurrent’ representing acute myeloid leukaemia with recurrent genetic abnormalities, (ii) ‘AML’ representing acute myeloid leukaemia, minimally differentiated; acute myeloid leukaemia without maturation; acute myeloid leukaemia with maturation broadly representing FAB M0, M1 and M2 and (iii) ‘lineage’ representing acute myelomonocytic leukaemia; acute monoblastic leukaemia; acute erythroid leukaemia (erythroid/myeloid and pure erythroid leukaemia); acute megakaryoblasic leukaemia and acute basophilic leukaemia broadly representing FAB M4 – M7 indicated that a significant number of patients in the AML group had MGEA6 present calls compared with patients in the lineage and recurrent groups (p=0.0185). However RAGE-1 expression did not segregate based on WHO this grouping. We examined whether in our patients population the M0/1/2 FAB subgroups were associated with a poorer survival rate than M3/4/5/6/7 and this was not found to be the case (p=0.27). RAGE-1 and MGEA6 present calls were also not found to be associated with poorer survival (p=0.891 and 0.956, respectively). RAGE-1 present calls did not to segregate with any single cytogenetic risk group (good, standard or poor). However using Chi2 pairwise comparisons the frequency of MGEA6 present calls in good versus poor, good versus standard and standard versus poor cytogenetic risk groups were all highly significant (each p<0.0001). This is the first study to suggest a differential expression of a CT antigen based on FAB or WHO subgroup or cytogenetic risk group. In addition, MGEA6 and RAGE-1 may provide suitable targets for the immunotherapy of AML particularly for patients in the M0, M1 and M2 subgroups
tumour antigens, arrays, myeloid leukaemia, immunotherapy, acute leukaemia
0007-1048
238-239
Guinn, Barbara-ann
728d28c9-a23d-413a-ba1d-4531005705d7
Gilkes, Amanda F.
ed9d4246-50b3-465a-aff3-bcd693f5e508
Mufti, Ghulam I.
52d2ed31-36e1-47c2-b644-2116b47c97bb
Burnett, Alan K.
50a1c448-e723-4da8-9b36-5074383e66de
Mills, Ken I.
be9c4b93-fda3-40b1-8514-9191652ab8b7
Guinn, Barbara-ann
728d28c9-a23d-413a-ba1d-4531005705d7
Gilkes, Amanda F.
ed9d4246-50b3-465a-aff3-bcd693f5e508
Mufti, Ghulam I.
52d2ed31-36e1-47c2-b644-2116b47c97bb
Burnett, Alan K.
50a1c448-e723-4da8-9b36-5074383e66de
Mills, Ken I.
be9c4b93-fda3-40b1-8514-9191652ab8b7

Guinn, Barbara-ann, Gilkes, Amanda F., Mufti, Ghulam I., Burnett, Alan K. and Mills, Ken I. (2006) The tumour antigens RAGE-1 and MGEA6 are expressed more frequently in the less lineage restricted subgroups of presentation acute myeloid leukaemia. British Journal of Haematology, 134 (2), 238-239. (doi:10.1111/j.1365-2141.2006.06135.x).

Record type: Article

Abstract

We have analysed the frequency of present calls for RAGE-1 and MGEA6 in patients based on FAB subclass. MGEA6 and RAGE-1 present calls were significantly higher in the M0/M1/M2 versus the M3/M4/M5/M6/M7 groups for both RAGE-1 (p<0.0001) and MGEA6 (p<0.0001). However dividing patients into three WHO subgroups as follows (i) ‘recurrent’ representing acute myeloid leukaemia with recurrent genetic abnormalities, (ii) ‘AML’ representing acute myeloid leukaemia, minimally differentiated; acute myeloid leukaemia without maturation; acute myeloid leukaemia with maturation broadly representing FAB M0, M1 and M2 and (iii) ‘lineage’ representing acute myelomonocytic leukaemia; acute monoblastic leukaemia; acute erythroid leukaemia (erythroid/myeloid and pure erythroid leukaemia); acute megakaryoblasic leukaemia and acute basophilic leukaemia broadly representing FAB M4 – M7 indicated that a significant number of patients in the AML group had MGEA6 present calls compared with patients in the lineage and recurrent groups (p=0.0185). However RAGE-1 expression did not segregate based on WHO this grouping. We examined whether in our patients population the M0/1/2 FAB subgroups were associated with a poorer survival rate than M3/4/5/6/7 and this was not found to be the case (p=0.27). RAGE-1 and MGEA6 present calls were also not found to be associated with poorer survival (p=0.891 and 0.956, respectively). RAGE-1 present calls did not to segregate with any single cytogenetic risk group (good, standard or poor). However using Chi2 pairwise comparisons the frequency of MGEA6 present calls in good versus poor, good versus standard and standard versus poor cytogenetic risk groups were all highly significant (each p<0.0001). This is the first study to suggest a differential expression of a CT antigen based on FAB or WHO subgroup or cytogenetic risk group. In addition, MGEA6 and RAGE-1 may provide suitable targets for the immunotherapy of AML particularly for patients in the M0, M1 and M2 subgroups

Full text not available from this repository.

More information

Submitted date: 26 May 2006
Published date: July 2006
Keywords: tumour antigens, arrays, myeloid leukaemia, immunotherapy, acute leukaemia

Identifiers

Local EPrints ID: 71571
URI: http://eprints.soton.ac.uk/id/eprint/71571
ISSN: 0007-1048
PURE UUID: cf4bcc19-2590-4c8e-a898-8087b5c4e80a

Catalogue record

Date deposited: 14 Dec 2009
Last modified: 19 Jul 2019 23:44

Export record

Altmetrics

Contributors

Author: Barbara-ann Guinn
Author: Amanda F. Gilkes
Author: Ghulam I. Mufti
Author: Alan K. Burnett
Author: Ken I. Mills

University divisions

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×